Purchases and Sales Made in Q4 2023 in Reneo Pharmaceuticals, Inc. (RPHM)
This table provides information about the institutional ownership of Reneo Pharmaceuticals, Inc. (RPHM) during Q4 2023. The information is specifically focused on institutions that hold shares of Reneo Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-727- 25.39% |
$974 - $6.13K
|
2.14K
$3.59K
|
|
|
Feb 08, 2024
Q4 2023
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-740- 6.53% |
$992 - $6.24K
|
10.6K
$17.8K
|
|
|
May 21, 2024
Q4 2023
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-2.53K- 39.64% |
$3.39K - $21.3K
|
3.86K
$6.48K
|
|
|
Feb 13, 2024
Q4 2023
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-3.62K- 3.01% |
$4.85K - $30.5K
|
117K
$196K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-4.91K- 33.69% |
$6.58K - $41.4K
|
9.67K
$16.2K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
- |
-12.3K- 42.72% |
$16.4K - $103K
|
16.4K
$27.6K
|
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-36.5K- 73.26% |
$48.9K - $308K
|
13.3K
$22.4K
|
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-53.7K- 68.72% |
$71.9K - $453K
|
24.4K
$41.1K
|
|
|
Jan 31, 2024
Q4 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-59.5K- 98.92% |
$79.7K - $501K
|
647
$1.09K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-73.6K- 37.07% |
$98.6K - $620K
|
125K
$210K
|
|
|
Feb 14, 2024
Q4 2023
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-119K- 5.01% |
$159K - $1M
|
2.25M
$3.78M
|
|
|
Feb 14, 2024
Q4 2023
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-391K- 34.24% |
$525K - $3.3M
|
752K
$1.26M
|